CEP
ECYT

Chicago Equity Partners’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Chicago Equity Partners’s Portfolio ECYT Stock Details ECYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-28,930
Closed -$514K – 922
2018
Q3 		$514K Buy
+28,930
New +$497K 0.02% 650

Other funds holding ECYT

OTC
Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return
CA
Claro Advisors Boston, Massachusetts $953M AUM 24.79% 1-Year Est. Return

Chicago Equity Partners's ECYT Position: Q4 2018 in Review

Chicago Equity Partners sold out of Endocyte, Inc. Common Stock (ECYT) in Q4 2018, closing a stake of 28,930 shares — an estimated $514K sold.

Chicago Equity Partners first reported a position in ECYT in Q3 2018 and held it in 1 quarter. The position peaked at $514K in Q3 2018. 2 funds tracked by Wall St. Rank hold ECYT as of Q4 2018.

  • Chicago Equity Partners reported no remaining Endocyte, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
  • Chicago Equity Partners sold 28,930 Endocyte, Inc. Common Stock shares in Q4 2018, an estimated $514K.
  • Chicago Equity Partners first reported a position in Endocyte, Inc. Common Stock in Q3 2018 and held it in 1 quarter.
  • Chicago Equity Partners's Endocyte, Inc. Common Stock position peaked at $514K in Q3 2018.
  • 2 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q4 2018.

Based on Chicago Equity Partners's 13F filing for Q4 2018, filed 5 Feb 2019.